Assistant Professor of Medicine
Cardiology
Dr. Martin S. Maron, MD
|
|
Give Review
Martin Maron practices Cardiology. He attended Tulane University School of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Martin Maron is a published MD. He published 88 publications, including: 'Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study.' Martin Maron accepts Medicare payments and is listed with Medicare.gov.
Publications
- Novel Approach Targeting the Complex Pathophysiology of Hypertrophic Cardiomyopathy: The Impact of Late Sodium Current Inhibition on Exercise Capacity in Subjects with...
- What Do Patients With Hypertrophic Cardiomyopathy Die from?
- Family History of Sudden Death Should Be a Primary Indication for Implantable Cardioverter Defibrillator in Hypertrophic Cardiomyopathy.
- Hypertrophic Cardiomyopathy in Children, Adolescents and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
- New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy.
- Coronary Embolization in Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm.
- Surviving malignant hypertrophic Cardiomyopathy with all major complications in a single patient.
- MY APPROACH to clinical management of hypertrophic Cardiomyopathy.
- Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic Cardiomyopathy.
- Advanced Heart Failure with Preserved Systolic Function in Nonobstructive Hypertrophic Cardiomyopathy: Under-Recognized Subset of Candidates for Heart Transplant.
- The 25-year genetic era in hypertrophic Cardiomyopathy: revisited.
- Hypertrophic Cardiomyopathy: Present and Future, With Translation Into Contemporary Cardiovascular Medicine.
- Asymptomatic young man with danon Disease.
- Cardiovascular magnetic resonance imaging for bicuspid aortic valve Syndrome: the time is now.
- Hypertrophic Cardiomyopathy with Right Ventricular Outflow Tract and Left Ventricular Intracavitary Obstruction.
- Left Atrial Remodeling in Hypertrophic Cardiomyopathy and Susceptibility Markers for Atrial Fibrillation Identified by Cardiovascular Magnetic Resonance.
- Contemporary Surgical Management of Hypertrophic Cardiomyopathy, the Need for More Myectomy Surgeons and Disease-Specific Centers, and the Tufts Initiative.
- The ever expanding spectrum of phenotypic diversity in hypertrophic Cardiomyopathy.
- Contrast-Enhanced CMR in HCM: What Lies Behind the Bright Light of Late Gadolinium Enhancement and Why It Now Matters.
- Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic Cardiomyopathy.
- Papillary Muscle Insertion Directly into the Anterior Mitral Leaflet in Hypertrophic Cardiomyopathy, Its Identification and Cause of Outflow Obstruction by Cardiac Mag...
- Risk stratification and outcome of patients with hypertrophic Cardiomyopathy >=60 years of age.
- Ventricular tachycardia/Fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
- Comparison of Circadian Rhythm Patterns in Tako-tsubo Cardiomyopathy Versus ST-Segment Elevation Myocardial Infarction.
- Significance of False Negative Electrocardiograms in Preparticipation Screening of Athletes for Hypertrophic Cardiomyopathy.
- Three-Dimensional Speckle-Tracking Echocardiography: Methodological Aspects and Clinical Potential.
- CMR With Late Gadolinium Enhancement in Genotype Positive-Phenotype Negative Hypertrophic Cardiomyopathy.
- Intermediate Signal Intensity Late Gadolinium Enhancement Predicts Ventricular TachyArrhythmias in Patients with Hypertrophic Cardiomyopathy.
- Left Ventricular Twist Mechanics in Hypertrophic Cardiomyopathy Assessed by Three-Dimensional Speckle Tracking Echocardiography.
- Double Or Compound Sarcomere Mutations In Hypertrophic Cardiomyopathy: A Potential Link To Sudden Death In The Absence Of Conventional Risk Factors.
- Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm in Brothers.
- Mitral Valve Abnormalities Identified by Cardiovascular Magnetic Resonance Represent a Primary Phenotypic Expression of Hypertrophic Cardiomyopathy.
- Successful Therapeutic Hypothermia in Patients With Hypertrophic Cardiomyopathy.
- "Speckled" Ventricular Septum in Hypertrophic Cardiomyopathy Revisited After 30 Years.
- Why not just call it tako-tsubo Cardiomyopathy: a discussion of nomenclature.
- Hypertrophic Cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging.
- Left ventricular remodeling in Heart failure: current concepts in clinical significance and assessment.
- Adipositas cordis: an uncommon Cardiomyopathy identified by cardiovascular magnetic resonance.
- Timing and significance of exercise-induced left ventricular outflow tract pressure gradients in hypertrophic Cardiomyopathy.
- Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.
- Survival after cardiac transplantation in patients with hypertrophic Cardiomyopathy.
- Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic Cardiomyopathy.
- Management implications of massive left ventricular hypertrophy in hypertrophic Cardiomyopathy significantly underestimated by echocardiography but identified by cardi...
- Risk stratification in hypertrophic Cardiomyopathy: is two-dimensional echocardiographic strain ready for prime time?
- Natural history and expansive clinical profile of stress (tako-tsubo) Cardiomyopathy.
- Peripheral vascular endothelial function in patients with hypertrophic Cardiomyopathy.
- The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic Cardiomyopathy.
- Impact of papillary and trabecular muscles on quantitative analyses of cardiac function in hypertrophic Cardiomyopathy.
- Utility of cardiovascular magnetic resonance in the diagnosis of Anderson-Fabry Disease.
- Imaging techniques in the evaluation and management of hypertrophic Cardiomyopathy.
- The case for myocardial ischemia in hypertrophic Cardiomyopathy.
- Hypertrophic Cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
- The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic Cardiomyopathy from idiopathic hypertrophic s...
- Images in cardiovascular medicine. Overlapping phenotypes: left ventricular noncompaction and hypertrophic Cardiomyopathy.
- Syncope and risk of sudden death in hypertrophic Cardiomyopathy.
- How should hypertrophic Cardiomyopathy be classified?: What's in a name? Dilemmas in nomenclature characterizing hypertrophic Cardiomyopathy and left ventricular hyper...
- Prevalence, clinical significance, and natural history of left ventricular apical Aneurysms in hypertrophic cardiomyopathy.
- Clinical profile and significance of delayed enhancement in hypertrophic Cardiomyopathy.
- Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic Cardiomyopathy.
- Spectrum and significance of electrocardiographic patterns, troponin levels, and thrombolysis in Myocardial infarction frame count in patients with stress (tako-tsubo)...
- Occurrence and frequency of Arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.
- Light-chain amyloidosis with echocardiographic features of hypertrophic Cardiomyopathy.
- Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic Cardiomyopathy.
- Sudden cardiac arrest in hypertrophic Cardiomyopathy in the absence of conventional criteria for high risk status.
- Right ventricular involvement in hypertrophic Cardiomyopathy.
- Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic Cardiomyopathy. Will there ever be a randomized trial?
- Stress Cardiomyopathy.
- Hypertrophic cardiomyopathy is predominantly a Disease of left ventricular outflow tract obstruction.
- What is the best approach for the assessment of left Atrial size? Comparison of various unidimensional and two-dimensional parameters with three-dimensional echocardio...
- Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic Cardiomyopathy.
- Gender-related differences in the clinical presentation and outcome of hypertrophic Cardiomyopathy.
- Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic Cardiomyopathy.
- Significance and relation between magnitude of left ventricular hypertrophy and Heart failure symptoms in hypertrophic cardiomyopathy.
- Acute and reversible cardiomyopathy provoked by stress in women from the United States.
- The case for surgery in obstructive hypertrophic Cardiomyopathy.
- Primary prevention of sudden death as a novel treatment strategy in hypertrophic Cardiomyopathy.
- Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic Cardiomyopathy.
- American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic Cardiomyopathy: Endorsed by the Am...
- Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement ...
- Relation of pulse pressure to blood pressure response to exercise in patients with hypertrophic Cardiomyopathy.
- [The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic Cardiomyopathy].
- [Myocardial hypoperfusion due to microvascular dysfunction in hypertrophic Cardiomyopathy: role of positron emission tomography].
- Sports and Arrhythmias: a report of the International Workshop Venice Arrhythmias 2009.
- Adrenergic receptor polymorphisms in patients with stress (tako-tsubo) Cardiomyopathy.
- The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic Cardiomyopathy: do patients with gradients really deserve prophylactic defib...
- Prevalence of hypertrophic Cardiomyopathy in an outpatient population referred for echocardiographic study.
- Assessment of QT dispersion as a prognostic marker for sudden death in a regional nonreferred hypertrophic Cardiomyopathy cohort.
Schools
Tulane University of Louisiana
New England Med Center Hosps
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Regional Pref Network EPO
- Regional Pref Network HMO
- Regional Pref Network HMO+
- Regional Pref Network POS+
- Regional Pref Network PPO
- Bakery & Confectionary Union Plan
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Community Health Network
- Connecticare
- Emblem Health
- Fallon Community Health Plan
- Fidelis Care HMO
- First Health (Coventry Health Care) PPO
- Group Health Cooperative
- Harvard Pilgrim Health Care PPO
- Medicare Advantage PFFS
- Direct Access
- Horizon Blue Cross Blue Shield HMO
- Horizon Blue Cross Blue Shield POS
- Horizon Blue Cross Blue Shield PPO
- Choice Care PPO
- MagnaCare PPO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- MVP Health Care
- National Elevator
- Network Health
- Freedom Plan
- Paramount
- PHP-Physicians Health Plan
- Planned Administration Inc
- QualCare HMO
- QualCare PPO
- Tufts Health Plans
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- United Healthcare
- WellCare
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
Tufts Medical Center -
Washington University - Barnes-Jewish Hospital -
Tulane University School of Medicine
Hospital
-
Tufts Medical Center
Drug Facts
| NPI NUMBER | 1225146905 | |
| NPPES Provider LastName | MARON | |
| NPPES Provider FirstName | MARTIN | |
| NPPES Provider ZIPCode | 021111526 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 91.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1225146905 |
| Last Name Of The Provider | MARON |
| First Name Of The Provider | MARTIN |
| View All |
Similar Doctors
|
|
Dr. Alberto Ramirez, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cevher Ozcan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raymond Y. Kwong, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Mary H. Zhang, MD |
|
|
Dr. Eugene Braunwald, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerasimos D. Zervos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ming Sum Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Fifer, MD
This Doctor is OpenDoctor Recommended.
|